Interleukin-32β ameliorates metabolic disorder and liver damage in mice fed high-fat diet

Obesity (Silver Spring). 2015 Mar;23(3):615-22. doi: 10.1002/oby.21001. Epub 2015 Feb 3.

Abstract

Objective: Chronic excessive food intake leads to energy imbalance, resulting in hepatic steatosis and inflammation. Interleukin-32 (IL-32) is known to be a pro-inflammatory cytokine associated with chronic inflammation and cancer. Therefore, the relationship between IL-32 and chronic excessive food intake-induced liver disease was investigated.

Methods: Male IL-32β transgenic and wild-type mice were fed a high-fat diet (HFD) for 15 weeks. They were compared with wild-type mice on a standard chow diet. Daily food intake, body and liver weight, serum biochemistry, histopathological analysis of the liver, and hepatic immune response were determined.

Results: IL-32β mice on HFD showed lower lipid accumulation, reduced infiltration of immune cells, and lower production of pro-inflammatory cytokines in the liver. The expression of the peroxisome proliferator-activated receptor γ (PPARγ) was downregulated and the adenosine 50-monophosphate (AMP)-activated protein kinase (AMPK) was activated in the liver of IL-32β mice compared to wild-type mice. Furthermore, IL-32β over-expression activated the AMPK pathway and IL-32β downregulation inactivated the AMPK pathway in HepG2 cells under high-glucose conditions.

Conclusions: These data suggest that IL-32β modulates lipid accumulation through inhibition of PPARγ expression and AMPK activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Body Weight / drug effects
  • Body Weight / genetics
  • Cytokines / metabolism
  • Diet, High-Fat*
  • Fatty Liver / genetics*
  • Fatty Liver / metabolism
  • Hep G2 Cells
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism
  • Interleukins / antagonists & inhibitors
  • Interleukins / genetics
  • Interleukins / physiology*
  • Lipid Metabolism / genetics
  • Male
  • Metabolic Diseases / genetics*
  • Metabolic Diseases / metabolism
  • Mice
  • Mice, Transgenic
  • PPAR gamma / metabolism
  • RNA, Small Interfering / pharmacology

Substances

  • Cytokines
  • Interleukins
  • PPAR gamma
  • RNA, Small Interfering
  • interleukin-32, mouse
  • AMP-Activated Protein Kinases